Liraglutide
GLP-1 receptor agonist. Findings and approvals depend on the specific medicine.
Search names: Saxenda, Victoza
Evidence
Catalogue entry · see sources
Describes the linked sources, not an overall score for product quality or effectiveness.Half-life
Vital: ~13 h
Transcribed from the recorded catalogue; experimental conditions are not always specified in the value field.Statistics reference: About 13 hours
Human information in catalogueContext and sources for the statistics reference
After subcutaneous administration.
About 13 hours · Catalogue information from PeptideTracker.ai; read the limitation above. PeptideTracker.ai · Liraglutide ↗
Half-life, duration of effect and shelf life are different measures. Catalogue values may differ between variants and administration routes. Curves continue to use their stated statistics reference.
Adverse effects and limitations
Adverse effects are not fully mapped in this entry. Consult the sources for the specific compound and use.
Sources and further reading
Vital · user-supplied screen recordings, 1 Nov 2026
Find researchPubMed · Liraglutide↗Research information, not a personal dosing plan. Last reviewed: 2026-11-01.